Profusa, Inc. Common Stock (PFSA)

US — Healthcare Sector
Peers: NVNO  EKSO  THAR  GOVX  XAIR  AYTU  CTXR  GLTO  IBIO  ATHA 

Automate Your Wheel Strategy on PFSA

With Tiblio's Option Bot, you can configure your own wheel strategy including PFSA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

 

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
PFSA
Published: August 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in cases and clinical study programs

Read More
image for news Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy
PFSA
Published: July 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

BERKELEY, Calif, July 21, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, today announced that it is initiating a Bitcoin treasury strategy via the execution of a Securities Purchase Agreement (the “ELOC”) with Ascent Partners Fund LLC, (“Ascent”), pursuant to which Ascent will purchase up to $100,000,000 of the Company's Common Stock. 100% of the net proceeds will be used to purchase Bitcoin (which can be used for debt repayment) provided that the Company's cash …

Read More
image for news Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

About Profusa, Inc. Common Stock (PFSA)

  • IPO Date 2025-07-14
  • Website https://profusa.com
  • Industry Medical - Equipment & Services
  • CEO Ben Hwang
  • Employees None
A digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia